OPEN as of November 1, 2026. The Foundation confirms the 2027 Young Investigator funding cycle opened October 1, 2026 and closes December 11, 2026.
National — Charlie Landers Foundation 2027 Ewing Sarcoma Young Investigator Award ($50,000; December 11, 2026)
2027 Young Investigator Award for pediatric Ewing sarcoma research: $50,000 for one year, deadline December 11, 2026. Qualified early-career MD/PhD researchers need a pediatric oncology mentor, 75% protected research time and an eligible nonprofit host institution.
Funding$50,000 one-year individual Young Investigator award; optional second $50,000 year subject to separate progress-based approval. Overall funding pool not published. No indirect costs.
DeadlineDecember 11, 2026. No submission time or time zone published. Foundation anticipates award announcement January 29, 2027, start May 1, 2027.
Last verified2026-11-01
Required next actionRead the official 2027 Young Investigator instructions at https://www.thecharlielandersfoundation.org/young-investigators-grant-application. Verify 5-year fellowship, 75% protected time, mentor and NIH award eligibility; prepare one PDF with cover, NIH biosketches, one-page abstract, four-page research plan, career development and mentoring plan, separate mentor letter, one-page budget and collaborator letters. Submit through the page form by December 11, 2026 and confirm the exact closing time with the Foundation.
Broad Eligibility
Early-career MD/PhD/MD-PhD investigators, including postdoctoral or clinical fellows, within five years after fellowship at deadline; translational research experience, 75% protected research time, qualified pediatric oncology mentor and eligible nonprofit recipient organization required. Holders of NIH R, P, F or K individual awards excluded; K12 and T32 institutional awards allowed. U.S. citizenship not required.
Atlas Analysis
Official-source verification November 1, 2026: Foundation's complete 2027 Young Investigator application and instructions https://www.thecharlielandersfoundation.org/young-investigators-grant-application, corroborated by October 7, 2026 cycle announcement. Individual award $50,000 one year with conditional second $50,000 year. Deadline December 11, 2026 without published clock time or time zone; earliest start May 1, 2027. MD/PhD eligibility, maximum five years after fellowship, required 75% protected time, pediatric oncology mentoring, NIH grant exclusions and allowed K12/T32, nonprofit awardee, direct costs and no indirect expenses verified. Published page does not specify a matching requirement, reimbursement schedule or recipient institution country restriction; applicant should confirm the latter with Foundation. Single-PDF proposal including mentoring plan, mentor letter, NIH biosketches and budget. Distinct applicant-facing research grant separate from general 2027 research program; not procurement.
2027 Ewing Sarcoma Young Investigator Award
The Charlie Landers Foundation is accepting applications for a distinct early-career research grant for pediatric Ewing sarcoma studies. The award supports innovative preclinical, translational and clinical research that could improve outcomes for patients. Funding is awarded to an eligible nonprofit institution or organization, not directly to a researcher as a personal stipend.
Applicant funding and deadline
Individual award: $50,000 for one year. Applications are due December 11, 2026; the funder does not state a closing hour or time zone. The Foundation anticipates announcing the recipient January 29, 2027, with a May 1, 2027 start. A second $50,000 year may be approved after progress review; it is not automatic. No separate total award pool is published.
Early-career eligibility
Applicants may be postdoctoral or clinical fellows and must hold an MD, PhD or combined MD/PhD. At the deadline, they must be within five years after fellowship, have translational research experience and dedicate at least 75% protected time during the award to research. Applicants currently holding NIH independent R or P awards or individual F or K training awards are ineligible; institutional K12 and T32 training grants are permitted. A research mentor with an established pediatric oncology record is required. Researchers do not need U.S. citizenship; applicants should confirm institution-specific geographic eligibility directly with the Foundation.
Allowable costs and reporting
Eligible budget categories include salary, fringe, travel, supplies and small equipment under $10,000. No indirect costs may be charged. The published instructions do not establish a matching percentage or a universal reimbursement schedule. Interim progress reporting is required at approximately six months, with a final report one month following the award’s end.
Application submission
Upload one combined PDF through the Foundation’s Young Investigator application form. Required materials include a one-page project cover, NIH-format investigator and mentor biosketches, one-page lay and scientific abstract, four-page research plan, one-page career development and mentoring plan, a separate mentor recommendation letter, one-page budget and justification, other funding disclosures and appropriate collaborator letters. The official page provides an example budget template.
Official application and full requirements: The Charlie Landers Foundation 2027 Young Investigator Award. Cycle announcement: October 7, 2026 announcement.
From Funding to Implementation · School Health Solution
Turn school-health funding into a clinically capable care model.
Dr. Miltie N9+ can support clinician-directed remote exams in school settings, helping care teams move beyond video-only encounters when a funded program calls for stronger pediatric access.
Source verificationReferenced source · www.thecharlielandersfoundation.orgAtlas last verified this record 2026-11-01. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗
